We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-10.21%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$6.49B
AUM Growth
+$329M
Cap. Flow
+$1.05B
Cap. Flow %
16.14%
Top 10 Hldgs %
17.7%
Holding
945
New
236
Increased
167
Reduced
92
Closed
153

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$112M
2
SWKS icon
Skyworks Solutions
SWKS
+$103M
3
STM icon
STMicroelectronics
STM
+$87.3M
4
ASML icon
ASML
ASML
+$71.6M
5
PANW icon
Palo Alto Networks
PANW
+$64.4M

Sector Composition

Rank Sector Weight
1 Healthcare 34.94%
2 Technology 31.31%
3 Financials 8.29%
4 Industrials 7.52%
5 Communication Services 4.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$366M 5.63%
969,000
+652,800
+206% +$267M
LLY icon
2
Eli Lilly
LLY
$1.07T
$161M 2.48%
496,003
+373,668
+305% +$112M
STM icon
3
STMicroelectronics
STM
$46B
$99.8M 1.54%
3,172,116
+2,342,701
+282% +$87.3M
SWKS icon
4
Skyworks Solutions
SWKS
$9.06B
$88.5M 1.36%
+955,660
New +$103M
BSX icon
5
Boston Scientific
BSX
$65.8B
$84.3M 1.3%
2,261,992
+430,333
+23% +$17.5M
JNJ icon
6
Johnson & Johnson
JNJ
$634B
$82.5M 1.27%
464,666
+178,706
+62% +$31.8M
ARW icon
7
Arrow Electronics
ARW
$10.9B
$70.5M 1.09%
629,372
+88,258
+16% +$10.3M
ALLO icon
8
Allogene Therapeutics
ALLO
$601M
$66.8M 1.03%
5,859,679
+5,427,529
+1,256% +$48.2M
BMY icon
9
Bristol-Myers Squibb
BMY
$127B
$65.5M 1.01%
850,180
+454,610
+115% +$34.6M
LEGN icon
10
Legend Biotech
LEGN
$4.3B
$64.4M 0.99%
1,171,051
JAZZ icon
11
Jazz Pharmaceuticals
JAZZ
$15.9B
$61.9M 0.95%
396,861
+221,818
+127% +$34.1M
ASML icon
12
ASML
ASML
$675B
$61.1M 0.94%
+128,342
New +$71.6M
PANW icon
13
Palo Alto Networks
PANW
$264B
$59.8M 0.92%
+726,714
New +$64.4M
MCHP icon
14
Microchip Technology
MCHP
$42.8B
$56.6M 0.87%
974,938
+550,738
+130% +$36.5M
MSFT icon
15
Microsoft
MSFT
$2.84T
$55.6M 0.86%
+216,551
New +$58.8M
ALKS icon
16
Alkermes
ALKS
$8.82B
$55.3M 0.85%
1,856,847
+542,441
+41% +$15.6M
ACN icon
17
Accenture
ACN
$89.9B
$53.8M 0.83%
+193,916
New +$58.3M
PLTR icon
18
Palantir
PLTR
$295B
$52.5M 0.81%
+5,784,318
New +$57.2M
MDT icon
19
Medtronic
MDT
$107B
$51.8M 0.8%
+577,581
New +$58.5M
MRK icon
20
Merck
MRK
$324B
$51.6M 0.8%
565,984
-303,407
-35% -$26.9M
VSH icon
21
Vishay Intertechnology
VSH
$5.86B
$48M 0.74%
2,695,891
+480,240
+22% +$9.12M
TTWO icon
22
Take-Two Interactive
TTWO
$43B
$44.8M 0.69%
+365,921
New +$46.6M
UBER icon
23
Uber
UBER
$134B
$44.6M 0.69%
+2,180,761
New +$57.9M
HII icon
24
Huntington Ingalls Industries
HII
$11.3B
$43.4M 0.67%
199,421
+57,059
+40% +$12.1M
AMD icon
25
Advanced Micro Devices
AMD
$851B
$42.7M 0.66%
+558,060
New +$52.2M

Similar funds

Woodline Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Woodline Partners held 945 positions worth $6.49B, up 5.3% from $6.16B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Woodline Partners deployed $1.05B of net new capital in Q2 2022, opening 236 new positions and adding to 167 existing holdings. Its largest new stake was Skyworks Solutions: 955,660 shares worth $88.5M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $169M trimmed.

  • Woodline Partners's largest Q2 2022 buy was Skyworks Solutions: 955,660 shares worth $88.5M.
  • Woodline Partners added most to Eli Lilly in Q2 2022, an estimated $112M increase.
  • Woodline Partners's biggest Q2 2022 reduction was Seagen Inc. Common Stock, cutting an estimated $169M.
  • Woodline Partners fully exited Cooper Companies in Q2 2022, selling an estimated $103M.
  • Woodline Partners's ten largest holdings make up 18% of its $6.49B portfolio in Q2 2022.
  • Woodline Partners opened 236 new positions and closed 153 in Q2 2022.
  • Woodline Partners's portfolio value rose 5.3% quarter-over-quarter to $6.49B.

Based on Woodline Partners's 13F filing for Q2 2022, filed 15 Aug 2022.